跳至主要内容
临床试验/CTRI/2021/06/034417
CTRI/2021/06/034417尚未招募3 期

Metformin in prevention of pregnancy induced hypertension in mothers at risk: a double blind randomized controlled trial.

IPGMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnant woman with
  • 1) previous history of preeclampsia or gestational hypertension
  • 2) Primigravida
  • 3) Obesity (BMI >35)
  • 4) Patient of diabetes
  • 5) pregnancy interval of more than 10 years
  • 6) family history of pre-eclampsia
  • 7) multi-fetal pregnancy
  • 8) high gestational age ( > 40 years) at presentation
  • 10)pre-existing vascular disease
  • 11) pre-existing kidney disease(including chronic kidney patient with GFR above 50 ml/min) 12) pregnant mothers who will come for their first visit in first trimester

排除标准

  • PATIENTS ALREADY ON METFORMIN
  • PATIENTS OF CKD STAGE 3 OR ABOVE
  • PATIENTS TAKING METFORMIN FOR TREATMENT OF PCOS
  • PATIENTS OF CHRONIC HYPERTENSION
  • KNOWN HYPERSENSITIVITY TO METFORMI

研究者

发起方
IPGMER

相似试验